Results 151 to 160 of about 1,719,974 (229)

Impact of diabetes mellitus on the menopausal experience: A scoping review

Diabetic Medicine, EarlyView.
Abstract Aims To identify, appraise and synthesise the current evidence relating to symptoms, experiences, management and impact of menopause on QoL among women with type 1 diabetes (T1DM) or type 2 diabetes (T2DM) and to identify evidence gaps. Methods We conducted a scoping review guided by Arksey and O'Mally's framework by searching CINAHL, MEDLINE,
Rachel Black, Felicity Hasson, Lisa King, Mark Davies, Deborah Muldrew, Paul Slater, Jenny Johnston, Dawn Adams, Rhonda Murphy, George Kernohan, Vivien Coates   +10 more
wiley   +1 more source

SoleFusion-Net: an explainable multimodal deep learning framework for diabetic foot syndrome classification in type II diabetes mellitus. [PDF]

Sci Rep
Sheikh MM, Balachandra M, G NV, Maiya AG.   +3 more
europepmc   +1 more source

Physicochemical and Biological Study of ^99mTc and ⁶⁸Ga Radiolabelled Ciprofloxacin and Evaluation of [^99mTc]Tc-CIP as Potential Diagnostic Radiopharmaceutical for Diabetic Foot Syndrome Imaging. [PDF]

Tomography, 2021
Koźmiński P, Gawęda W, Rzewuska M, Kopatys A, Kujda S, Dudek MK, Halik PK, Królicki L, Gniazdowska E.   +8 more
europepmc   +1 more source

Efficacy and Safety of SGLT2 Inhibitors in Patients With Genetic Lipodystrophy: A Real‐Life Experience From a National Reference Network

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim Lipodystrophy syndromes are rare diseases with metabolic and cardiovascular consequences. This study explores the metabolic and renal effects of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in patients with genetic lipodystrophy. Patients and Methods Patients with familial partial lipodystrophy (n = 57) or congenital generalised ...
Léna Robert, Ines Belalem, Corinne Vigouroux, Hippolyte Dupuis, Marie Christine Vantyghem, Mathilde Simonson, Estelle Nobecourt, Héléna Mosbah, Sophie Beliard, Stéphanie Jellimann, Sonja Janmaat, Camille Vatier, Sophie Lamothe   +12 more
wiley   +1 more source

[Use of human umbilical cord acellular matrix for soft tissue defects in patient with diabetic foot syndrome (case report)]. [PDF]

Probl Endokrinol (Mosk)
Chebotarev SV, Tovpeko DV, Kalyuzhnaya LI, Kotova ME, Kondratenko AA, Volov DA, Khominets VV, Chernov VE, Zemlyanoy DA, Salukhov VV.   +9 more
europepmc   +1 more source

Clinical, Pathological and Microbiological Evaluation of Diabetic Foot Syndrome. [PDF]

Medicina (Kaunas), 2020
Uivaraseanu B, Bungau S, Tit DM, Fratila O, Rus M, Maghiar TA, Maghiar O, Pantis C, Vesa CM, Zaha DC.   +9 more
europepmc   +1 more source

Quality of Diabetes Care Among Older Adults in Germany—Results of the Study on Health of Older People 2022/2023 Compared With Previous National Health Surveys

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims The study aims (1) to evaluate the quality of diabetes care considering guideline‐recommended medical therapies, cardiometabolic factors, and self‐management of health behaviours among older adults with diabetes in Germany, and (2) to examine time trends.
Yong Du, Giselle Sarganas, Beate Gaertner, Maike Buchmann, Judith Fuchs, Hannelore Neuhauser, Christin Heidemann   +6 more
wiley   +1 more source

Social Support and Disease Acceptance in Patients with Diabetic Foot Syndrome and Their Relationship with the Metabolic Control of the Disease. [PDF]

J Clin Med
Kobos E, Serafin O, Kostrzewa-Zabłocka E, Stefanowicz-Bielska A.   +3 more
europepmc   +1 more source

[Diabetic foot syndrome-Part 1 : Definition, pathophysiology, diagnostics and classification]. [PDF]

Chirurg, 2021
Rümenapf G, Morbach S, Rother U, Uhl C, Görtz H, Böckler D, Behrendt CA, Hochlenert D, Engels G, Sigl M, Kommission PAVK und Diabetisches Fußsyndrom der DGG e. V..   +10 more
europepmc   +1 more source

Therapies for Cardiovascular‐Kidney‐Liver‐Metabolic Syndrome: Reappraisal of Fibrates

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Cardiovascular disease, chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM), obesity and metabolic dysfunction‐associated steatohepatitis (MASH) frequently coexist and share overlapping pathophysiology, forming the proposed cardiovascular‐kidney‐liver‐metabolic (CKLM) syndrome.
Virginia Anagnostopoulou, Christoforos K. Travlos, Lucas Lage Marinho, Thomas A. Mavrakanas, João Pedro Ferreira, Abhinav Sharma   +5 more
wiley   +1 more source